Pathos AI Raises $237 Million in Series E at About a $3 Billion Valuation
Image: TokenPost
Bristol Myers Squibb led the round. Pathos AI plans to expand Foundry and advance four cancer drug candidates in clinical development.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.
